BioAge Labs Inc
BioAge Labs Inc (BIOA) Wheel Strategy
BIOA wheel strategy scan found 5 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 190.1%.
Read more
Running a BIOA wheel strategy lets you generate consistent premium income on BioAge Labs Inc while setting your own entry and exit prices on the underlying. BioAge Labs Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own BIOA, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best BIOA wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on BIOA, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable BIOA wheel from a losing one.
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation.
The company was incorporated in 2015 and is based in Richmond, California.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the BIOA wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your BIOA wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
| Nov 20, 2026 | 7.50 | $0.10 | $2.50 | -0.29 | 64 | 3% | 58.3% | 190.1% | 0 |
| Dec 18, 2026 | 7.50 | $0.10 | $2.50 | -0.29 | 92 | 3% | 55.6% | 132.2% | 39 |
| Jan 15, 2027 | 7.50 | $0.10 | $2.50 | -0.28 | 120 | 3% | 53.7% | 101.4% | 17 |
| Oct 16, 2026 | 7.50 | $0.25 | $0.48 | -0.33 | 29 | 3% | 65.2% | 79.7% | 52 |
| Dec 18, 2026 | 5.00 | $0.20 | $0.43 | -0.13 | 92 | 3% | 93.4% | 33.7% | 198 |
As of September 18, 2026
Run the Wheel on BIOA With Confidence
Find the best BIOA wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.
Start your 14-day free trial→